Epsilon Aminocaproic Acid

DRUG3 trials

Sponsors

NYU Langone Health, Heekin Orthopedic Research Institute, Wake Forest University Health Sciences

Conditions

Complication of Extracorporeal CirculationOsteoarthritisPediatric Cardiac SurgeryScoliosis

Phase 4

Tranexamic Acid (TXA) Versus Epsilon Aminocaproic Acid (EACA) Versus Placebo for Spine Surgery

CompletedNCT00958581

NYU Langone HealthScoliosis

Start: 2008-12-31End: 2012-09-30Updated: 2018-01-17

A Pilot Study Comparing Anti-Inflammatory Effects Of TXA Versus EACA In Pediatric Congenital Heart Surgery

CompletedNCT02656472

Wake Forest University Health SciencesComplication of Extracorporeal Circulation, Pediatric Cardiac Surgery

Start: 2016-02-29End: 2017-04-30Updated: 2024-10-24

Unknown Phase

Epsilon Aminocaproic Acid Vs. Tranexamic Acid Vs. Placebo for Prevention of Blood Loss in Total Knee Arthroplasty

Heekin Orthopedic Research InstituteOsteoarthritis

Start: 2012-04-30End: 2016-12-31Updated: 2016-07-26

Related Papers

A prospective, randomized, double-blinded single-site control study comparing blood loss prevention of tranexamic acid (TXA) to epsilon aminocaproic acid (EACA) for corrective spinal surgery.

2010-04-0640 citations